/ Side by side
Mod GRF 1-29 vs CJC-1295
A neutral, side-by-side look at Mod GRF 1-29 and CJC-1295: what each one is, its class, half-life, storage, and the public sources behind it. Educational reference only, not medical advice, dosing, or a recommendation to use either compound.
Mod GRF 1-29
CJC-1295 without DAC · Modified GRF(1-29) · Sermorelin analog
Full profile →CJC-1295
with DAC · mod GRF 1-29
Full profile →| Attribute | Mod GRF 1-29 | CJC-1295 |
|---|---|---|
| Category | Growth Hormone | Growth Hormone |
| Half-life | Short, in the range of tens of minutes, and far shorter than the DAC version | With DAC ~6-8 days; without DAC |
| Common vial | Varies | 2, 5, 10 mg |
| Reference | Verified | Verified |
What is Mod GRF 1-29?
The 1-29 fragment of growth hormone releasing hormone carrying four amino acid substitutions for stability, without the drug affinity complex that extends the related CJC-1295. It is the shorter-acting member of that pair, which is the reason the two are catalogued separately. Not approved for human use.
Sources
- Endocrinology 1985: structural requirements for activation of pituitary adenylate cyclase by GRF analogs
What is CJC-1295?
A synthetic growth-hormone-releasing hormone (GHRH) analog that binds pituitary GHRH receptors to stimulate growth hormone secretion. The DAC (drug affinity complex) version binds albumin for a much longer half-life than the unmodified peptide.
Sources
- Teichman et al., J Clin Endocrinol Metab 2006
Educational reference only, compiled from public sources. Not medical advice, diagnosis, treatment, or a dosing recommendation, and not a recommendation to use any compound. Many compounds listed are research materials not approved for human use. Consult a qualified professional.